Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule

Cancer Research

Volumn 61, Issue 17, 2001, Pages 6377-6381

  Hemminki, A ^a   Dmitriev, I ^a   Liu, B ^a   Desmond, R A ^a   Alemany, R ^a   Curiel, D T ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; SECRETORY PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CANCER; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CARCINOMA, SQUAMOUS CELL; GENE THERAPY; HELA CELLS; HUMANS; MICE; MICE, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035418580     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Replication-selective microbiological agents: Fighting cancer with targeted germ warfare
2. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
3. Selectivity of TAG-72 targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro
4. Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer
5. Selective gene delivery to head and neck cancer cells via an integrin-targeted adenoviral vector
6. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
7. Transduction efficiency of adenoviral vectors in colorectal cancer cells is determined by the presence of the coxsackie adenovirus receptor
8. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures
9. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells
10. Update on adenovirus and its vectors
11. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy
12. Protein tyrosine kinases and cancer
13. Efficient oncolysis by a replicating adenovirus (Ad) in vivo is critically dependent on tumor expression of primary Ad receptors
14. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells
15. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
16. A novel conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of Ela-deleted adenoviral vectors
17. Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus
18. Complementary adenoviral vectors for oncolysis
19. An overview of methods for the analysis of longitudinal data
20. An introduction to the mixed procedure
21. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells
22. EGF-induced redistribution of erbB2 on breast tumor cells: Flow and image cytometric energy transfer measurements